UTHR
UNITED THERAPEUTICS Corp
NASDAQ · Healthcare · Biotechnology · US
$593.54
+1.20%Forward multiples
Based on analyst estimates
- P/E forward
- 20.67x
- P/E 2026E
- 22.48x
- P/E 2027E
- 19.48x
- P/E 2028E
- 16.23x
- P/S forward
- 7.75x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.63x
- PEG TTM
- 0.94x
- Price / book
- 3.98x
- Price / sales
- 8.07x
- Price / cash flow
- 15.11x
Enterprise value
- Enterprise value
- $22.8B
- EV / sales
- 7.23x
- EV / EBITDA
- 13.60x
- EV / EBIT
- 16.24x
- Market cap
- $25.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026